Jardines Acquires Australian Radiology Group I-MED for $2.4 Billion

Hong Kong-based holding company Jardine Matheson has announced the acquisition of Australian radiology group I-MED in a deal valued at $2.4 billion. This acquisition stands out as the first large-scale transaction following the company's strategic restructuring process. I-MED operates as a leading healthcare provider offering medical imaging services in Australia. Jardine Matheson's move reflects its interest in the healthcare sector and its strategy to diversify its portfolio. The deal is noted as a significant step aligned with the company's regional growth objectives. Following a previous strategic review, Jardine Matheson decided to restructure and refocus its business units. The acquisition of I-MED is considered part of this restructuring and aims to strengthen the company's presence in the healthcare services field. The completion of the deal is subject to regulatory approvals. Jardine Matheson anticipates that this acquisition has long-term value creation potential and will contribute to its shareholders. This is not investment advice.